0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query globaldata pluristem therapeutics inc psti financial strategic swot analysis review 0.Your search for "" gave back 1489332 results.
Bone Marrow Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets...
Catalog:
Global Markets Direct
April 2022
Price: USD 2,500.00
Global biodefense market will reach $15.85 billion by 2030, growing by 6.2% annually over 2020-2030 owing to the rising need for military and...
Catalog:
Grace Market Data
June 2020
Price: USD 2,980.00
Acorda Therapeutics, Inc - Strategy, SWOT and Corporate Finance Report Summary Acorda Therapeutics, Inc - Strategy, SWOT and Corporate Finance Report...
MarketLine
February 2022
Price: USD 175.00
Oncternal Therapeutics, Inc - Strategy, SWOT and Corporate Finance Report Summary Oncternal Therapeutics, Inc - Strategy, SWOT and Corporate Finance...
MarketLine
March 2022
Price: USD 175.00
Cell Transplant is a procedure in which cells, often stem cells or cells that can be induced to become pluripotent stem cells, are transferred to a...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Bone Marrow Transplant Rejection - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
November 2019
Price: USD 2,000.00
Assertio Therapeutics Inc - Strategy, SWOT and Corporate Finance Report Summary Assertio Therapeutics Inc - Strategy, SWOT and Corporate Finance...
MarketLine
December 2020
Price: USD 175.00
Graft Versus Host Disease (GVHD) (Immunology) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog:
Global Markets Direct
July 2021
Price: USD 2,500.00
Oncternal Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oncternal Therapeutics, Inc. - Strategy, SWOT and Corporate...
MarketLine
January 2023
Price: USD 175.00
Celldex Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Celldex Therapeutics, Inc. - Strategy, SWOT and Corporate Finance...
MarketLine
December 2022
Price: USD 175.00
Windtree Therapeutics Inc - Strategy, SWOT and Corporate Finance Report Summary Windtree Therapeutics Inc - Strategy, SWOT and Corporate Finance...
MarketLine
December 2022
Price: USD 175.00
Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance...
MarketLine
January 2023
Price: USD 175.00
Adipose tissue stem cells (ASCs), known as multipotent stem cells, are most commonly used in the clinical applications in recent years. The global...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Adipose tissue stem cells (ASCs), known as multipotent stem cells, are most commonly used in the clinical applications in recent years. The global...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
November 2019
Price: USD 2,000.00
